Oragenics's market cap is currently $3.55M. The company's EPS TTM is $-5.725; its P/E ratio is ―; Oragenics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 37.65K	$ 131.52K	$ 86.99K	$ 0.00	$ 0.00
Gross Profit	$ -15.45M	$ 86.85K	$ 45.75K	$ -51.70K	$ -62.62K
Operating Income	$ -20.90M	$ -14.42M	$ -15.77M	$ -26.64M	$ -15.88M
EBITDA	$ -20.88M	$ -14.23M	$ -15.65M	$ -26.37M	$ -15.50M
Net Income	$ -20.66M	$ -14.16M	$ -15.73M	$ -26.44M	$ -15.57M
Balance Sheet
Cash & Short-Term Investments	$ 3.48M	$ 11.43M	$ 27.27M	$ 17.64M	$ 18.27M
Total Assets	$ 4.97M	$ 14.76M	$ 28.23M	$ 18.68M	$ 19.75M
Total Debt	$ 322.51K	$ 624.53K	$ 797.21K	$ 898.92K	$ 979.65K
Net Debt	$ -3.16M	$ -10.80M	$ -26.47M	$ -16.74M	$ -17.29M
Total Liabilities	$ 1.80M	$ 1.75M	$ 1.74M	$ 1.84M	$ 2.52M
Stockholders' Equity	$ 3.17M	$ 13.01M	$ 26.49M	$ 16.84M	$ 17.23M
Cash Flow
Free Cash Flow	$ -7.29M	$ -15.36M	$ -13.51M	$ -16.95M	$ -13.04M
Operating Cash Flow	$ -7.29M	$ -15.23M	$ -13.47M	$ -16.95M	$ -13.01M
Investing Cash Flow	$ -936.28K	$ -115.52K	$ -43.88K	$ 0.00	$ -25.21K
Financing Cash Flow	$ 283.88K	$ -494.92K	$ 23.14M	$ 16.32M	$ 11.10M

Currency in USD

Oragenics Earnings and Revenue History

Income Statement >

Oragenics Debt to Assets

Balance Sheet >

Oragenics Cash Flow

Cash Flow >

Oragenics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing